Viewpoints

Overview of diabetic eye disease

Imaging for diabetic retinopathy

Use of OCT-A for patients with diabetes

Optimizing diabetes health management

Diabetes management: Communication between ODs and MDs

Challenges to diabetes management

ADA guidelines for DR/DME management

Treatment options for DR/DME

Emerging agents for the treatment of DR/DME

Videos

A panel of experts in ophthalmology and optometry review the diagnosis and treatment of diabetic eye disease including emerging agents in the field.

Updates in DME, diabetic retinopathy

Introduction and definition of macular degeneration

Identifying a typical patient with Wet AMD

Clinical trials vs real-world data on wet AMD

Anti-VEGF agents for treatment of wet AMD

Personal experience with anti-VEGF agents for wet AMD

Reasons for switching between agents for wet AMD

Safety concerns with anti-VEGF agents for wet AMD

Role of biosimilars in management of wet AMD

Compounds and home monitoring device in development for wet AMD

The impact of COVID-19 on the management of wet AMD 

The use of telemedicine for wet AMD treatment

Final thoughts on the progression of treatment for wet AMD

Caroline R Baumal, MD, Thomas Albini, MD, Aleksandra Rachitskaya, MD, and Michael Singer, MD, discuss a number of topics pertaining to wet age-related macular degeneration (wet AMD) including the diagnosis and clinical manifestations, treatment options, and the impact of the COVID-19 pandemic on management of wet AMD.
  

Advancement in the management of wet AMD

Diabetic Macular Edema

Diabetic Retinopathy

Wet AMD